What is the recommended treatment for iron deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Iron Deficiency Anemia

Start with ferrous sulfate 200 mg once daily as a single morning dose on an empty stomach, which is the preferred first-line treatment due to superior tolerability and effectiveness compared to multiple daily dosing. 1

First-Line Oral Iron Therapy

Ferrous sulfate 200 mg once daily is the standard treatment for iron deficiency anemia in most patients, taken as a single morning dose rather than divided throughout the day. 1 This regimen maximizes absorption while minimizing gastrointestinal side effects that reduce compliance. 2

Dosing Strategy

  • Take iron on an empty stomach for optimal absorption, though taking with food is acceptable if gastrointestinal side effects occur. 1
  • Add vitamin C (ascorbic acid) 500 mg with each iron dose to enhance absorption, particularly when response is suboptimal. 1
  • For doses ≥60 mg, consider alternate-day dosing rather than daily administration, as oral iron doses ≥60 mg stimulate an acute increase in hepcidin that persists 24 hours and reduces absorption of subsequent doses. 2
  • Avoid afternoon or evening dosing after a morning dose, as the circadian increase in plasma hepcidin is augmented by morning iron administration. 2

Expected Response and Duration

  • Hemoglobin should rise by approximately 2 g/dL after 3-4 weeks of treatment. 1
  • Continue oral iron therapy for 3 months after anemia correction to fully replenish iron stores, not just until hemoglobin normalizes. 1
  • If no hemoglobin rise occurs within 4 weeks, assess for non-adherence, ongoing blood loss, or malabsorption before continuing the same regimen. 1

Monitoring Schedule

  • Check hemoglobin and red cell indices at 3-month intervals for the first year, then again after another year. 1
  • Provide additional iron supplementation if hemoglobin or MCV falls below normal during follow-up. 1

Intravenous Iron Therapy

Switch to intravenous iron as first-line treatment in the following specific circumstances:

  • Clinically active inflammatory bowel disease 3
  • Hemoglobin below 100 g/L (10 g/dL) 3
  • Previous intolerance to oral iron 3
  • Patients requiring erythropoiesis-stimulating agents 3
  • Post-bariatric surgery patients due to disrupted duodenal absorption mechanisms 1
  • Failure to respond to oral iron after 4 weeks despite compliance and absence of acute illness 3

The European Crohn's and Colitis Organization guidelines conclude that intravenous iron is more effective, shows a faster response, and is better tolerated than oral iron in these populations. 3

Special Population Considerations

Inflammatory Bowel Disease Patients

  • Treat active inflammation first to enhance iron absorption and reduce iron depletion. 1
  • Use oral iron only in patients with mild anemia whose disease is clinically inactive and who have not been previously intolerant to oral iron. 3
  • Diagnostic criteria for iron deficiency depend on inflammation level: In remission, serum ferritin <30 mg/L indicates deficiency; with inflammation present, ferritin up to 100 mg/L may still indicate iron deficiency. 3

Pregnant Women

  • Start oral, low-dose (30 mg/day) supplements at the first prenatal visit for primary prevention. 3
  • For treatment of anemia, prescribe 60-120 mg/day of elemental iron. 3
  • When hemoglobin normalizes for gestational stage, decrease the dose to 30 mg/day. 3
  • If hemoglobin is less than 9.0 g/dL or hematocrit less than 27.0%, refer to a physician familiar with anemia during pregnancy for further evaluation. 3

Celiac Disease Patients

  • Ensure strict adherence to gluten-free diet to improve iron absorption before expecting full response to supplementation. 1

Diagnostic Workup for Unexplained Iron Deficiency Anemia

The underlying cause must be identified while treating the anemia:

  • Patients >45 years should undergo bidirectional endoscopy (gastroscopy and colonoscopy) due to increasing incidence of gastrointestinal malignancy with age. 1
  • Patients <45 years should have endoscopy only if upper GI symptoms are present; otherwise, perform antiendomysial antibody testing to exclude celiac disease. 1
  • Small bowel investigation is not routinely recommended after negative bidirectional endoscopy unless red flags are present (involuntary weight loss, abdominal pain, elevated CRP). 4

Critical Pitfalls to Avoid

  • Do not prescribe multiple daily doses – once-daily or alternate-day dosing improves tolerability with similar or better efficacy. 1, 2
  • Do not stop iron when hemoglobin normalizes – continue for 3 months to replenish stores. 1
  • Do not continue ineffective oral iron beyond 4 weeks – reassess and switch to IV iron if hemoglobin fails to rise. 1
  • Do not overlook vitamin C supplementation when oral iron response is suboptimal. 1
  • Do not fail to identify the underlying cause while supplementing iron. 1
  • Do not use doses exceeding 200 mg daily – higher doses decrease fractional absorption and increase side effects without improving efficacy. 2

Management of Treatment Failure

If anemia does not resolve within 6 months despite appropriate therapy:

  • Reassess for ongoing blood loss, malabsorption syndromes, non-adherence, or misdiagnosis. 1
  • Consider further gastrointestinal investigation with small bowel evaluation. 1
  • Consider hematology consultation for complex cases. 1
  • In patients where GI blood loss exceeds intestinal absorption capacity (e.g., intestinal angiodysplasia), intravenous iron supplementation is required. 5

References

Guideline

Iron Deficiency Anemia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and management of iron deficiency anemia in the 21st century.

Therapeutic advances in gastroenterology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.